HCA Healthcare, Inc. $HCA Shares Acquired by Vestcor Inc

Vestcor Inc lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 15.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 26,268 shares of the company’s stock after buying an additional 3,473 shares during the quarter. Vestcor Inc’s holdings in HCA Healthcare were worth $12,263,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HCA. Norges Bank acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $374,037,000. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after purchasing an additional 649,058 shares during the period. Finally, Danske Bank A S acquired a new position in HCA Healthcare in the third quarter worth $115,530,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.9%

Shares of NYSE HCA opened at $372.29 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The firm’s 50-day simple moving average is $439.51 and its 200 day simple moving average is $477.20. The stock has a market cap of $82.59 billion, a P/E ratio of 12.80, a P/E/G ratio of 1.15 and a beta of 1.12.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Oppenheimer decreased their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Wall Street Zen downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. KeyCorp decreased their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. TD Cowen decreased their price objective on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a report on Monday, April 27th. Finally, Jefferies Financial Group reissued a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a report on Friday, April 24th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $506.14.

View Our Latest Research Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.